Search Within

Genitourinary Oncology Service

  1. "Clinical Chemistry"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
  3. Editorial (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (10)
  3. Department of Pathology and Laboratory Medicine (3)
  4. Surgery (3)
  5. Population Sciences Research Program (2)
  6. Urology (2)

More Groups

People
  1. Howard Scher (8)
  2. Morton Schwartz (3)
  3. Ann Dnistrian (2)
  4. Carol Smith (2)
  5. Daniel Danila (2)
  6. Delia Schwartz (2)

More People

Years
  1. 2020 (2)
  2. 2019 (1)
  3. 2011 (1)
  4. 2010 (1)
  5. 2009 (2)
  6. 1996 (1)

More Years

Publications
  1. Clinical Chemistry (10)
Publishers
  1. American Association for Clinical Chemistry (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fragment size analysis may distinguish clonal hematopoiesis from tumor-derived mutations in cell-free DNA
    Research Letter

    Marass, F.; Stephens, D.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Solit, D. B.; Diaz, L. A.; Tsui, D. W. Y.
    Clinical Chemistry (2020)

    Fulltext@MSK | Save
  • Toward standardization of preanalytical procedures for cell-free DNA profiling
    Editorial

    Tsui, D. W. Y.; Barnett, E.; Scher, H. I.
    Clinical Chemistry (2020)

    Fulltext@MSK | Save
  • Circulating tumor cells in prostate cancer: From discovery to clinical utility
    Review

    Pantel, K.; Hille, C.; Scher, H. I.
    Clinical Chemistry (2019)

    Fulltext@MSK | Save
  • Circulating cancer cells and their clinical applications
    Journal Article

    Diamandis, E. P.; Pantel, K.; Scher, H. I.; Terstappen, L.; Lianidou, E.
    Clinical Chemistry (2011)

    Fulltext@MSK | Save
  • Detection of androgen receptor mutations in circulating tumor cells: Highlights of the long road to clinical qualification
    Journal Article

    Lilja, H.; Scher, H. I.
    Clinical Chemistry (2010)

    Fulltext@MSK | Save
  • Design and validation of a multiplexed gene expression panel to guide treatment selection in prostate cancer (PCa)
    Meeting Abstract

    Rai, A. J.; Danila, D. C.; Sung, C.; Yu, C. T.; Scher, H.; Fleisher, M.
    Clinical Chemistry (2009)

    Fulltext@MSK | Save
  • Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer: Concordance with CellSearch assay and association with bone metastases and with survival
    Journal Article

    Helo, P.; Cronin, A. M.; Danila, D. C.; Wenske, S.; Gonzalez-Espinoza, R.; Anand, A.; Koscuiszka, M.; Väänänen, R. M.; Pettersson, K.; Chun, F. K. H.; more...
    Clinical Chemistry (2009)

    Fulltext@MSK | Save
  • Evaluation of the Hybritech free (PSA-f) and total PSA (PSA-t)
    Meeting Abstract

    Schwartz, M. K.; Smith, C.; Schwartz, D.; Dnistrian, A.; Fair, W.; Fleshner, N.; Scher, H.
    Clinical Chemistry (1996)

    Fulltext@MSK | Save
  • Platinum measurements in plasma and tissue cytosol by atomic absorption spectrophotometry
    Meeting Abstract

    Menendez-Botet, C. J.; Coit, D.; Bajorin, D.; Schwartz, M.
    Clinical Chemistry (1990)

    Fulltext@MSK | Save
  • NSE as a tumor marker
    Meeting Abstract

    Savoia, M.; Schwartz, D.; Smith, C.; Bhalla, R.; Dnistrian, A.; Kushner, B.; Kris, M. G.; Scher, H. I.; Schwartz, M. K.
    Clinical Chemistry (1987)

    Fulltext@MSK | Save